July 6, 2014

Effects of ex vivo Gamma-Tocopherol on Airway Macrophage Function in Healthy and Mild Allergic Asthmatics



J Innate Immun. Author manuscript; available in PMC May 8, 2014.
Published in final edited form as:
Published online May 8, 2013. doi:  10.1159/000350234
PMCID: PMC3939603
NIHMSID: NIHMS539930
Marianne Geiser, PhD,a,c,*,1 John C. Lay, DVM, PhD,a,b William D. Bennett, PhD,a,c Haibo Zhou, PhD,a,d Xiaoyan Wang, PhD,a,d David B. Peden, MD, MPH,a,b,c and Neil E. Alexis, PhDa,b

Abstract

Elevated inflammation and altered immune responses are features found in atopic asthmatic airways. Recent studies indicate gamma-tocopherol (GT) supplementation can suppress airway inflammation in allergic asthma. We studied the effects of in vitro GT supplementation on receptor-mediated phagocytosis and expression of cell surface molecules associated with innate and adaptive immunity on sputum-derived macrophages. Cells from non-smoking healthy (n = 6) and mild house dust mite-sensitive (HDM) allergic asthmatics (n = 6) were treated ex vivo with GT (300 μM) or saline (control). Phagocytosis of opsonized Zymosan A bioparticles (S. cerevisiae) and expression of surface molecules associated with innate and adaptive immunity were assessed using flow cytometry. GT caused significantly decreased (P - 0.05) internalization of attached Zymosan bioparticles and decreased (P - 0.05) macrophage expression of CD206, CD36 and CD86 in allergic asthmatics but not in controls. Overall, GT caused down-regulation of both innate and adaptive immune response elements and atopic status appears to be an important factor.
Keywords: allergy, asthma, macrophages, phagocytosis, flow cytometry, gamma-tocopherol, host defense

PubReader format: click here to try

Formats:

No comments:

Post a Comment